Advertisement
Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
598 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
854 days ago
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
954 days ago
Sensex, Nifty Climb In Early Trade; Auto Stocks Take Lead
Indian shares were sharply higher on Friday, with sentiment aided by the prospect of easing global trade tensions after China said it is evaluating trade talks with the U.S.
RTTNews
|
21 minutes ago
Australian Market Extends Early Gains In Mid-market
The Australian stock market is extending its early gains in mid-market moves on Friday, adding to the gains in the previous six sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving a tad above the 8,200 level, with gains in iron ore miners, financial and energy stocks partially offset by weakness in gold miners and technology stocks.
RTTNews
|
1h 23min ago
Asian Markets Track Wall Street Higher
Asian stock markets are mostly higher on Friday, following the positive cues from Wall Street overnight, amid optimism about possible trade deals, with US President Donald Trump saying he has "potential" trade deals with India, South Korea and Japan as well as expressed optimism about a resolution with China. Traders are also booking some profits following the recent upside in the markets.
RTTNews
|
1h 44min ago
Sensex, Nifty Seen Higher At Open
Indian shares look set to open a tad higher on Friday as markets resume trading after a holiday on Thursday for Maharashtra Day.
RTTNews
|
2h 4min ago
Thai Bourse May Reclaim 1,200-Point Level
Ahead of Thursday's Labor Day holiday, the Thai stock market had moved higher in four straight sessions, gathering more than 50 points or 4.2 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,200-point plateau and it's expected to tick higher again on Friday.
RTTNews
|
2h 38min ago
